PTHS · Pelthos Therapeutics Inc. · Executive Compensation
$20.26
-0.76 (-3.59%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared May 14, 2026
The latest filing states the doubt was alleviated.
“in prior periods, management disclosed substantial doubt about the Company's ability to continue as a going concern. The conditions and events that previously raised substantial doubt have been alleviated by management's plans and actions.”View the 10-Q filed May 14, 2026
Market Cap
$84.95M
Shares
3.83M
Volume · Oct 1
33.21K
Avg daily vol (3M)
58.25K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Scott Plesha | Chief Executive Officer | $4,153,168 |
| Francis Knuettel II | Former Chief Financial Officer; Former Chief Executive Officer | $2,288,234 |
| Sai Rangarao | Chief Commercial Officer | $1,723,407 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Francis Knuettel II | Former Chief Financial Officer; Former Chief Executive Officer | $1,205,255 |
| Scott Plesha | Chief Executive Officer | — |
| Sai Rangarao | Chief Commercial Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Francis Knuettel II | Chief Executive Officer and Chief Financial Officer | $307,010 |
| Francis Knuettel | CEO | $307,010 |
| Eric Lang | Chief Medical Officer | $287,502 |
| Christian Kopfli | Former Chief Executive Officer, Former Chief Strategy Officer, and Former Vice Chairman | $160,913 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Francis Knuettel II | Chief Financial Officer, Treasurer and Secretary | Terminated | 2026-05-21 |
| Francis Knuettel II | Chief Financial Officer | Terminated | 2026-04-10 |
| John M. Gay | treasurer and secretary | Appointed | 2026-04-10 |
| John M. Gay | Chief Financial Officer | Appointed | 2026-04-10 |
| Andrew J. Einhorn | Board of Directors | Appointed | 2025-12-23 |
| Frank Knuettel | Chief Financial Officer | Appointed | 2025-07-02 |
| Sai Rangarao | Chief Commercial Officer | Appointed | 2025-07-02 |
| Francis Knuettel II | principal accounting officer | Appointed | 2025-07-02 |
| Francis Knuettel II | Chief Financial Officer | Appointed | 2025-07-02 |
| Scott Plesha | Chief Executive Officer | Appointed | 2025-07-02 |
| Scott Plesha | President | Appointed | 2025-07-02 |
| Dr. Eric Lang | Chief Medical Officer | Terminated | 2025-07-02 |
| Francis Knuettel | President | Terminated | 2025-07-02 |
| Francis Knuettel | Chief Executive Officer | Terminated | 2025-07-02 |
| Richard Baxter | director | Appointed | 2025-07-02 |
| Ezra Friedberg | director | Appointed | 2025-07-02 |
| Todd Davis | director | Appointed | 2025-07-02 |
| Matthew Pauls | director | Appointed | 2025-07-02 |
| Scott Plesha | director | Appointed | 2025-07-02 |
| Peter Greenleaf | director | Appointed | 2025-07-02 |
| Dr. Richard Malamut | director | Appointed | 2025-07-02 |
| Chia-Lin Simmons | director | Resigned | 2025-07-02 |
| Ezra Friedberg | director | Resigned | 2025-07-02 |
| Todd Davis | director | Resigned | 2025-07-02 |
| Francis Knuettel II | director | Resigned | 2025-07-02 |